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Over the past decade, microRNAs (miRNAs) have emerged as essential posttranscriptional
regulators of gene expression. Though a great deal has been discovered about miRNA
genomics, biogenesis, mechanisms, and functions, the challenge of attributing phenotypes
of altered miRNA expression to speciﬁc targets still remains. Here, we apply the
existing target protector concept of blocking miRNA action at a single binding site in the
3′untranslated region (3′UTR) of its target to a plasmid-based approach. We optimize and
demonstrate target protector efﬁcacy in vitro, where it blocks repression of a luciferase
construct and an endogenous protein. Using the developing mouse cortex as a model,
we validate that target protectors are effective in vivo, where protectors for the miR-19a
binding sites in the Pten 3′UTR alter proliferation and speciﬁcation of neural progenitors,
phenocopying Pten ectopic expression phenotypes. Our study introduces a new tool for
analyzing speciﬁc miRNA:target interactions across mammalian developmental systems,
facilitating further miRNA functional discoveries.
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INTRODUCTION
MicroRNAs (miRNAs) are an extensive class of small non-coding
RNAs that are critically important throughout development
(Carrington and Ambros, 2003; Bartel, 2004; Alvarez-Garcia
and Miska, 2005; Kloosterman and Plasterk, 2006). They regu-
late gene expression posttranscriptionally through incorporation
into a RNA-induced silencing complex (RISC), which uses par-
tial sequence complementarity to bind target messenger RNAs
(mRNAs), usually in the 3′untranslated region (3′UTR; Lewis
et al., 2003). RISC binding can lead to blocking translation or
enhancing the decay of target mRNAs, the ﬁnal result being
downregulation of the target protein (Bartel, 2004). Hundreds
of miRNAs have been identiﬁed in the genomes of mammals
including rodents and humans, and each miRNA can regulate
many mRNAs in a cell-type speciﬁc manner, leading to a com-
plex network of interactions (Landgraf et al., 2007). It is estimated
that between 25 and 60% of human transcripts are regulated by
miRNAs (Lewis et al., 2005; Lim et al., 2005; Friedman et al., 2009).
Conditional knockout and knockdown techniques have been
used to examine the roles of miRNAs; however, there can be
difﬁculty in interpreting molecular mechanisms underlying the
observed phenotypes due to the large number of potential tar-
gets of each miRNA. Groups working in model systems such
as zebraﬁsh and Xenopus have bypassed this obstacle through a
morpholino target protector approach, using sequence comple-
mentarity to block a miRNA from binding to a speciﬁc site (Choi
et al., 2007; Bonev et al., 2011; Stanton and Giraldez, 2011). How-
ever, morpholinos are not a tractable tool in mammals and their
short length of activity limits their application in developmental
systems.
We here have developed a plasmid-based target protector
system to tease apart the physiological roles of miRNAs in mam-
malian systems. Previous work in our lab has shown that in the
developing cortex,miR-19a targets Pten mRNA (Bian et al., 2013).
In the developing mouse cortex, Pten functions to repress pro-
genitor expansion; therefore its repression by miR-19a results in
increased proliferation (Groszer et al., 2001; Zheng et al., 2008).
Thus, the miR-19a:Pten relationship provides an ideal readout for
testing Pten derepression through target protectors. Here, we have
designed and optimized target protectors for the miR-19a binding
sites in the Pten 3′UTR. We demonstrate that these target protec-
tors can be electroporated in utero to allow functional investigation
of a speciﬁc miRNA:mRNA interaction during cortical develop-
ment in vivo. Our results provide a useful tool for investigation of
long term, speciﬁc miRNA–target interactions both in vitro and in
vivo using a plasmid-based target protector system.
MATERIALS AND METHODS
TARGET PROTECTOR DESIGN
Protectors were designed as perfectly complementary sequence
covering themiR-19a binding sites in the Pten 3′UTR. ThemiRNA
seed binding sequence was centered in the target protector, with
complementary sequence on each side. Outside of the comple-
mentary sequence, restriction sites can be added as necessary for
a cloning strategy.
For the second miR-19a binding site, target protectors with
three lengths of complementarity to thePten3′UTRweredesigned:
22, 40, and 60 nucleotides (nt; Figure 2A). All of the target protec-
tors were designed to be the same total length as the 60 nt protector
and included junk sequences to increase their length as necessary,
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keeping the target protector in the middle of the construct. We
ordered the target protectors as complementary oligonucleotides.
After annealing, protectors were subcloned and inserted into
the pCAGIG vector for electroporation and pCDNA3.1 for the
luciferase assay.
miR-19a EXPRESSION CONSTRUCT
The precursor hairpin sequence of miR-19a and ∼100 nt of
genomic sequence ﬂanking each side of the hairpin sequence
was ampliﬁed by PCR from the genomic locus of the
mouse miR-17-92 cluster. Sequences of primers are as fol-
lowing: miR-19a: F: 5′-CAGCTCGAGCAATCCAAGTCA-3′, R:
5′-GCAGGCTCTACATCGACAC-3′. To generate the miR-19a
expression construct, the miRNA fragment was inserted into
pcDNA3.1 for transfection in cell lines, and pCAGIG for elec-
troporation.
LUCIFERASE ASSAY
pGL4.13 ﬁreﬂy luciferase (Promega) vector was used for mak-
ing constructs containing ampliﬁed 3′UTRs of targets. pGL4.73
renilla luciferase (Promega) was used as a transfection control.
Plasmid DNA was quantiﬁed by UV spectrophotometry and
used for transfection in a 6:2:1 ratio (protector:miRNA:target
luciferase constructs) in Neuro2a (N2a) cells using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol.
Luciferase was activated using the Dual-Luciferase Reporter Assay
kit (Promega) using themanufacturer’s protocol and readon aVic-
tor3 1420 multilabel counter (Perkin Elmer). Results were shown
as ﬁreﬂy luciferase activity normalized to renilla as controls.
To make the 3′UTR construct for the luciferase assay, a cDNA
fragment encoding the mouse Pten 3′UTR was ampliﬁed and
subcloned into the pGL4.13 luciferase vector. The ﬁrst miR-
19a binding site was mutated using QuikChange II Site-Directed
Mutagenesis Kit (Agilent Technologies) according to manufac-
turer’s instructions. All the primers for cloning of targets in
the 3′UTR and their mutation are listed as the following: Pten-
3′UTR: F: 5′-CATCTAGAATACATCCACAGGGTTTTGACA-3′,
R: 5′-TTGAAGCCCTAATCCCAACTCT-3′; Pten-3′UTR-miR-
19a-mut1: 5′-CCGGGTTCACGTCCTACCCCATTACAATTGT
GGCAACAGATAAGTTT-3′.
NORTHERN BLOT ANALYSIS
Total RNA was isolated from N2a cells transfected with either the
60 nt target protector or the pcDNA3.1 empty vector using Tri-
zol reagent (Invitrogen) according to manufacturer’s instructions.
RNA samples and 0.1–2 kb RNA ladder (Invitrogen) were dena-
tured at 70◦C for 15 min and cooled on ice. Ethidium bromide
was added to the RNA ladder for visualization. The DNA con-
trol sample was denatured at 95◦C and cooled on ice. Samples
were loaded onto a 1% formaldehyde agarose gel and separated at
room temperature. After running, the ladder band locations were
marked on the gel.
Sampleswere transferredonto anitrocellulosemembraneusing
a semi-dry transfer method overnight. After transfer, the ladder
band locations were marked on the membrane. After cross-
linking for 4 h at 80◦C, the membrane was hybridized at 50◦C
overnight using a denaturedDNAprobe for the 60nt target protec-
tor. The probe was body-labeled with digoxygenin (DIG)-labeled
nucleotides using the DIG DNA Labeling Kit (Roche), following
manufacturer instructions. After washing, the RNA was detected
using the CDP-star chemiluminescent substrate (Roche).
WESTERN BLOT ANALYSIS
Expression levels of Pten were analyzed by theWestern blot analy-
sis. Protein extracts were harvested by lysing N2a cells transfected
with combinations miR-19a, 60 nt target protector, and empty
vector with RIPA lysis buffer (150 mM NaCl, 1 mM Na4P2O7,
1 mM NaF, 1 mM EDTA, 1 mM PMSF, 2 mM Na3VO4, 1% NP-
40, 50 mM Tris, pH 7.5) with completeTM EDTA-free protease
inhibitor mixture (Roche Diagnostics, Indianapolis, IN, USA).
The protein samples were boiled in SDS sample buffer for 10 min
before loading onto 10% Tris–glycine gels as 10 μg for each lane
and transferred onto PVDF membrane (Pall Corporation, Pen-
sacola, FL, USA). For immunoblotting, membranes were blocked
with 5% (w/v) non-fat milk powder in 0.05% TBST [50 mM
Tris–Cl, pH 7.5, 150 mM NaCl, with 0.05% (v/v) Tween-20] and
incubated at 4◦C overnight with the following primary antibod-
ies which were diluted in 0.05% TBST with 5% non-fat milk:
Pten and actin. After washing with TBST, membranes were incu-
bated with speciﬁc HRP-conjugated secondary antibodies for 1 h
at room temperature followed with extended washes with TBST.
Immunoblot reactions were visualized using chemiluminescent
substrate (Pierce, Rockford, IL,USA) on Kodak BioMax light ﬁlms
(Kodak, Rochester, NY, USA). The intensities of the bands were
densitometrically quantiﬁed with the image software ImageJ.
The following antibodies were used: anti-Pten (rabbit, 1:1,000;
Cell Signaling) and anti-Actin (rabbit, 1:400; Sigma).
IN UTERO ELECTROPORATION
In utero electroporation was performed as described by Saito
(2006). Brieﬂy, electroporation was conducted at E13.5 and the
brain tissues were harvested 24 h later at E14.5. Plasmid DNA was
prepared using the EndoFree plasmid maxi kit (Qiagen) accord-
ing to manufacturer’s instructions, and diluted to 2.5 μg/μl. DNA
solution was injected into the lateral ventricle of the cerebral cor-
tex, and electroporated with ﬁve 50-ms pulses at 35 V using an
ECM830 electrosquareporator (BTX).
Wild type CD-1mice were used for all experiments. For staging
of embryos,midday of the day of vaginal-plug formation was con-
sidered E0.5; the ﬁrst 24 h after birth were deﬁned as P0. Animal
use was overseen by the Animal Facility at Weill Cornell Medical
College.
TISSUE PREPARATION AND IMMUNOHISTOCHEMISTRY
Mouse brains were ﬁxed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) over night, incubated in 25–
30% sucrose in PBS, embedded in OCT and stored at −80◦C
until use. Brains were sectioned (10–14 μm) using a cryostat. For
antigen recovery, sections were incubated in heated (95–100◦C)
antigen recovery solution (1 mM EDTA, 5 mM Tris, pH 8.0)
for 15–20 min, and cooled down for 20–30 min. Before apply-
ing antibodies, sections were blocked in 10% normal goat serum
(NGS) in PBS with 0.1% Tween-20 (PBT) for 1 h. Sections were
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incubated with primary antibodies at 4◦C overnight and visu-
alized using goat anti-rabbit IgG-Alexa-Fluor-488 and/or goat
anti-mouse IgG-Alexa-Fluor-546 (1:350, Molecular Probes) for
1.5 h at room temperature. Images were captured using a Leica
digital camera under a Zeiss confocal microscope.
Primary antibodies against the following antigens were used:
bromodeoxyuridine (BrdU; 1:50, DSHB), Ki67 (1:500, Abcam),
Pax6 (1:200, Covance, rabbit), Tbr2 (1:500, Abcam), GFP (1:1000,
Abcam, chicken), and GFP (1:1000, Rockland, rabbit).
CELL COUNTING
Coronal sections were collected in the medial cortical region (at
levels between the anterior commissure and the anterior hip-
pocampus). At least four sections from each brain and three brains
from different litters were chosen for antibody labeling. Positive
cells were quantiﬁed in ﬁxed areas of 318 μm × 318 μm and
normalized to the averaged empty vector control value.
STATISTICS
For the luciferase and Western blot assays, three independent
experiments were performed. For electroporated mouse sections,
at least three brains from each group were analyzed. Statisti-
cal comparison was made by an analysis of variance (unpaired
Student’s t-test).
RESULTS
TARGET PROTECTOR DESIGN AND IN VITRO TESTING
In a typical cell, miRNAs target multiple mRNAs through par-
tial sequence complementarity (Figure 1A). The concept behind
target protectors is that a construct with perfect complementarity
to a speciﬁc miRNA-binding site will outcompete the miRNA for
binding at that site (Figure 1B). Thus, a single miRNA target is
derepressed while the others remain regulated, allowing analysis
of the effects of a single miRNA:mRNA relationship. To apply this
concept in mammalian development, we designed plasmid-based
mRNA target protectors using miR-19a:Pten regulation, since our
previous work and others have demonstrated the targeting effect
of miR-19a on Pten (Mu et al., 2009; Olive et al., 2009; Mavrakis
et al., 2010; Bian et al., 2013).
To optimize the minimum length of sequence complementar-
ity necessary for maximum protector efﬁcacy, we designed target
protectors with three lengths of complementarity for the sec-
ond miR-19a binding site in the Pten 3′UTR (Figure 2A). We
chose the shortest length of 22 nt because this is the approximate
size of most miRNAs (Figure 2A). We also designed protectors
of 40 and 60 nt to increase complementarity, binding strength,
and speciﬁcity (Figure 2A). Our basic rules for protector design
are: (1) each protector is centered over the predicted miRNA
seed binding site, (2) the protectors have perfect complementar-
ity along the length of the 3′UTR, and (3) the protector must
not overlap any other known functional sites in the 3′UTR. For
the 22 and 40 nt target protectors, junk DNA sequences were
inserted outside of the complementary region so that the over-
all length of all three constructs was constant with the 60 nt
protector.
We hypothesized that an effective target protector would block
miR-19a activity in the 3′UTRof Pten in a luciferase assay, resulting
FIGURE 1 |Target protectors block miRNA action at a specific mRNA
binding site. (A) miRNAs regulate multiple targets through sequence-
speciﬁc binding in the 3′UTR. (B)Target protectors block miRNA action at a
single target, while other targets remain regulated.
in a recovery of luciferase activity. To test the target protectors,
we used a luciferase vector containing only the second miR-19a
binding site of the Pten 3′UTR (the ﬁrst miR-19a binding site
was mutated in the Pten 3′UTR), and cotransfected it with miR-
19a and each target protector in N2a cells. In the absence of
any target protector, luciferase activity of the Pten 3′UTR was
signiﬁcantly decreased (Figure 2B). The 22 and 40 nt protec-
tors did not show any signiﬁcant recovery of luciferase activity,
while the 60 nt protector showed a signiﬁcant, almost complete
recovery of activity (Figure 2B). Neither miR-19a nor any of the
target protectors had an effect on the luciferase activity of the
Pten 3′UTR containing a mutation in both miR-19a binding sites
(Figure 2B). Our results indicate that the 60 nt target protec-
tor is the most effective at blocking miR-19a activity at the Pten
3′UTR
60 nt TARGET PROTECTOR BLOCKS miR-19a ACTIVITY IN VITRO
To ensure that the 60 nt target protector was transcribed and
expressed as expected, we performed a northern blot assay using
RNA extracted from N2a cells transfected with either the tar-
get protector or an empty vector. As a positive control, we also
included digested vector DNA containing the protector. Based
on the insert size and the predicted transcription start site and
polyadenylation signals of the vector, the expect RNA size to be
about 305 nt (Figure 3A). The protector is detected at the expected
size in target protector transfected RNA and is not detected in
the empty vector-transfected RNA, indicating that the protector is
transcribed and expressed (Figure 3B).
Wepreviously established thatmiR-19a regulatesPtenposttran-
scriptionally by preventing its translation (Bian et al., 2013). Thus,
we hypothesized that transfection of the protector should result in
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FIGURE 2 |Target protectors for Pten block miR-19a-induced repression.
(A) Binding sites of miR-19a in the Pten 3′UTR and complementary target
protector sequences for the second miR-19a binding site. The seed binding
sequence of miR-19a is highlighted in green, and the entire length of
miR-19a along the Pten 3′UTR is highlighted in red. (B) Luciferase assays
of target protector effects on miR-19a repression of the second miR-19a
binding site in the Pten 3′UTR. miR-19a reduced luciferase activity in the
absence of target protector. The 60 nt target protector but not the 22 or
40 nt target protector recovered luciferase activity of the Pten 3′UTR.
Neither miR-19a nor the 60 nt target protector had an effect on the
luciferase activity of the full length Pten 3′UTR when the miR-19a binding
sites were mutated. Data are presented as mean ± SEM; n = 3
luciferase assays; p values in relation to control (***p < 0.01). n.s., not
signiﬁcant.
increased endogenous Pten protein in N2a cells. Indeed, aWestern
blot assay showed that transfection of only exogenous miR-19a
results in a decrease of endogenous Pten, while cotransfection
of exogenous miR-19a and the target protector, or the protec-
tor alone signiﬁcantly rescues the endogenous Pten protein levels
(Figures 3C,D). Our results suggest that the plasmid-based target
protectors are transcribed and work to block posttranscriptional
regulation by miRNAs.
60 nt TARGET PROTECTOR BLOCKS miR-19a ACTIVITY IN VIVO
Having established that the plasmid-based target protector is effec-
tive in vitro, we sought to apply it in vivo, where such a tool
can provide insight to the function of speciﬁc miRNA–mRNA
interactions during development. We previously established that
miR-19a targeting of Pten promotes progenitor cell expansion
in the developing mouse cortex (Bian et al., 2013). We expected
that blocking miR-19a activity with the target protector will
result in decreased proliferation of progenitors. To observe the
maximum effect of blocking miR-19a binding to Pten, we also
designed a 60 nt target protector for the ﬁrst binding site in
the Pten 3′UTR and used in utero electroporation to introduce
protectors for both miR-19a binding sites in the Pten 3′UTR into
the embryonic day 13.5 (E13.5) cortex, analyzed at E14.5. The
numbers of BrdU+ and Ki67+ cells were signiﬁcantly decreased
after Pten target protectors were electroporated compared to
empty vector electroporation, suggesting a functional result of
the blockade of miR-19a silencing effect on Pten expression
(Figure 4).
To test further whether decreased proliferation of neural
progenitors in target protector electroporation is caused by up-
regulation of Pten, which is usually suppressed by miR-19a, we
electroporated full lengthPten containing the 3′UTRwithmiR-19a
binding sites (Pten-FL-3′UTR).We observed a signiﬁcant decrease
in both BrdU+ and Ki67+ cells upon electroporation of the Pten
overexpression construct compared to empty vector electropora-
tion (Figures 4B,D).When Pten-FL-3′UTR was co-electroporated
with exogenous miR-19a, the numbers of BrdU+ and Ki67+ cells
were recovered to wild type levels, indicating that the change is
dependent on miR-19a activity on the Pten 3′UTR (Figure 4).
Our results demonstrate that plasmid-based target protectors can
be electroporated into developing cortices to block miRNA action
at a speciﬁc target.
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FIGURE 3 |Target protectors are transcribed and effective in vitro. (A)
Schematic vector map of the 60 nt target protector in pcDNA3.1. (B)The 60 nt
target protector and control target protector DNA were detected by Northern
blot assays at the expected size. No target protector was detected in RNA
extracted from empty vector-transfected cells. (C,D)The endogenous protein
levels of Pten were decreased upon transfection of miR-19a but recovered
upon cotransfection of miR-19a and the 60 nt target protector. Transfection of
the 60 nt target protector alone also showed an increase in Pten. Data are
presented as mean ± SD; n = 3 separate protein extractions; p values in
relation to control (***p < 0.001).
TARGET PROTECTORS REVEAL THE ROLE OF miR-19a REPRESSION OF
Pten IN THE DEVELOPING CORTEX
During corticogenesis, the transition of proliferative radial glia
cells (RGCs) and intermediate progenitor (IP) into postmitotic
neurons is tightly regulated in order to generate an appropriate
amount of neurons while maintaining a progenitor pool. Our
previous work has shown that the miRNA family miR-17-92, con-
taining miR-19a, promotes RGC proliferation (Bian et al., 2013).
To validate that miR-19a targeting of Pten is responsible for RGC
proliferation, we introduced Pten target protectors into E13.5 cor-
tices, which should result in a decrease of RGCs. We found that
the number of Pax6+ RGCs is signiﬁcantly decreased, while the
number of Tbr2+ IPs is not changed (Figure 5).
To conﬁrm further that Pten is responsible for the decrease
of RGCs, we electroporated Pten-FL-3′UTR, which we expected
to show a similar phenotype as the Pten target protectors, in
E13.5 cortices collected at E14.5. Indeed, the number Pax6+ RGCs
was decreased and the number of Tbr2+ IPs was not changed
(Figures 5B,D). When Pten-FL-3′UTR and miR-19a were co-
electroporated, the number of Pax6+ RGCs was recovered, while
the number of Tbr2+ IPs remained unchanged (Figure 5). These
results show that miR-19a targeting of Pten is critical for prolifera-
tion of RGCs in the developing cortex but does not affect the IP cell
population. Using our Pten target protectors, we further demon-
strate that the speciﬁc effects of miR-19a on RGC expansion occur
through silencing Pten.
DISCUSSION
miRNAs have been proven to play critical roles in development
of invertebrates and vertebrates (Carrington and Ambros, 2003;
Alvarez-Garcia andMiska, 2005; Kloosterman and Plasterk, 2006).
Since one miRNA has multiple targets, it has been a daunting task
to demonstrate which genes are major targets in speciﬁc cells or
tissues during development. In this study, we have designed a
plasmid-based tool for analyzing speciﬁc miRNA:target relation-
ships, shown that it works effectively in vitro and in vivo, and
applied it to amiRNA:mRNApair in the developingmouse cortex.
In the past, many studies have examined the roles of indi-
vidual miRNAs by removing them globally or conditionally. In
Drosophila and mice, genetic mutants have been generated, while
in other systems such as zebraﬁsh or Xenopus, morpholinos or
other antisense oligonucleotides have been used to knockdown
miRNAs (Sokol, 2005; Karres et al., 2007; Ventura et al., 2008;
Woltering and Durston, 2008; Conte et al., 2010; Rasmussen et al.,
2010). miRNA sponges with multiple miRNA-binding sites have
also been used to soak upmature miRNAs (Ebert et al., 2007; Loya
et al., 2009; Ebert and Sharp, 2010).While thesemethods provide a
genetic approach to explore the overall function of a miRNA, they
lack the power to attribute any phenotype to a particular mRNA
target. Later, morpholino-based target protectors were applied
in zebraﬁsh and Xenopus to examine the importance of miRNA
repression of a speciﬁc target (Choi et al., 2007; Bonev et al., 2011;
Stanton and Giraldez, 2011). While this technique has been useful
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FIGURE 4 |Target protectors block miR-19a repression of Pten in
the developing mouse cortex. (A–D) Electroporation of the 60 nt
target protector at E13.5 for analysis at E14.5 signiﬁcantly decreased
the number of BrdU-incorporating or Ki67+ proliferative cells
colabeled with GFP in the cortex. Ectopic expression of full length
Pten containing the 3′UTR (Pten-FL-3 ′UTR) showed a similar effect,
while co-electroporation of Pten-FL-3 ′UTR and miR-19a ablated this
effect. Data are presented as mean ± SD; n ≥ 3 for all
electroporations; p values in relation to control (***p < 0.001).
Scale bar: 50 μm.
FIGURE 5 | miR-19a targeting of Pten is responsible for RGC
expansion in the developing mouse cortex. (A,B) miR-19a targeting
of Pten is important for RGC expansion. Introduction of the 60 nt
target protector at E13.5 for analysis at E14.5 signiﬁcantly decreased
the number of RGCs colabeled with GFP and Pax6. Ectopic expression
of Pten-FL-3 ′UTR showed a similar effect, while co-electroporation of
Pten-FL-3 ′UTR and miR-19a ablated this effect. (C,D) Ectopic expression
of the 60 nt target protector, Pten-FL-3 ′UTR, or Pten-FL-3 ′UTR and
miR-19a had no effect on the number of IPs colabeled with GFP and
Tbr2. Data are presented as mean ± SEM; n ≥ 3 for all electroporations;
p values in relation to control (***p < 0.001). n.s., not signiﬁcant.
Scale bar: 50 μm.
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in somemodel organisms, it is not applicable tomanymammalian
systems.
We have shown that plasmid-based target protectors are effec-
tive in mammalian systems. They are a simple and clean method
for blocking miRNA action at a single target, eliminating uncer-
tainty surrounding which mRNA targets are responsible for a
phenotype. Because they are plasmid-based, these target protec-
tors can be applied across a wide variety of model systems and
tissues. They also have long lasting expression and can be used to
study gene functions at any stage of development.
Here, we used in utero electroporation to introduce target
protectors into the developing cortex; however, this is not the
only application of plasmid-based target protectors. These pro-
tectors could also be used in viral transfection, or they could
be incorporated to create transgenic lines. For any method of
delivery, a conditional expression vector can be used to analyze a
miRNA:target relationship in a speciﬁc cell type and at a speciﬁc
stage. These target protectors also have disease treatment poten-
tial, as they could be used to increase expression of a dysregulated
gene by blocking a miRNA.
While our plasmid-based target protectors are shown to be
very effective for dissecting themiR-19a:Pten relationship, we have
applied them toothermiRNA:target pairswithmixed results. First,
it is important to reiterate that these protectors are not applica-
ble to every miRNA-binding site: if the protector overlaps another
miRNA-binding site, protein binding site, or interferes with other
RNA processing signals, then the results will be difﬁcult to inter-
pret. Another factor that may inﬂuence protector function is RNA
secondary structure, either of the target RNA or the protector
itself. To alleviate this problem, we recommend designing and
testing target protectors of multiple lengths; though we found the
60 nt target protector to be the most effective, this may not be true
in every case.
Another reason that a single target protector might not show a
phenotype is that miRNAs often target multiple members of the
same pathway. Thus, derepression of a single pathway member
may be masked by continued regulation of the rest of the path-
way. In this study, we successfully introduced target protectors for
two miR-19a binding sites and we recommend this combinatorial
approach for derepression of multiple pathway members. How-
ever, this method is limited by the maximum amount of DNA
that can be introduced at a time. A large amount of each target
protector is required to see an effect, which would be diluted by
including multiple target protectors.
Plasmid-based target protectors open myriad opportunities in
the miRNA ﬁeld for dissecting speciﬁc miRNA:target interac-
tions in mammalian model systems. These target protectors are
applicable across tissues and developmental systems, and can be
introduced in many ways. Here, we have presented basic concepts
of target protector design and shown their application both in
vitro and in vivo. We also revealed an important role of the miR-
19a:Pten interaction in the developing cortex, demonstrating the
great potential of this essential new tool.
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